Wegovy pill is not America’s silver bullet
The US Food and Drugs Association (FDA) has this week approved a Wegovy weight-loss pill, a more convenient…
FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and…
Inside the FDA’s vaccine uproar and the push to overhaul the U.S. immunization system
Six days after a senior FDA official sent a sweeping internal email claiming that COVID-19 vaccines had caused…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…
U.S. vaccine policy could see big changes in 2026
WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of…
America’s FDA just approved the first GLP-1 weight-loss pill. Here’s what to know
Eli Lilly has sought FDA approval for its own weight-loss pill as the two pharmaceutical giants continue their…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
Female libido pill gets expanded approval for menopause by FDA
U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now…
Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals’ (AMPH) Narrative?
In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide…
Amphastar Announces FDA Approval for Teriparatide Injection
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the…
Regulatory reform can unlock access to biosimilars
Every day, I think about the patients waiting for medicines that could change, or even save, their lives.…
Otsuka’s kidney therapy gets accelerated FDA approval
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and…